Kinetic, spectroscopic and thermodynamic characterization of the Mycobacterium tuberculosis adrenodoxin reductase homologue FprA.
暂无分享,去创建一个
[1] D. Young,et al. Molecular mechanisms of isoniazid: a drug at the front line of tuberculosis control. , 1993, Trends in microbiology.
[2] F. Studier,et al. Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. , 1986, Journal of molecular biology.
[3] J. Lambeth,et al. Adrenodoxin reductase. Properties of the complexes of reduced enzyme with NADP+ and NADPH. , 1976, The Journal of biological chemistry.
[4] T. Poulos,et al. Redox control of the catalytic cycle of flavocytochrome P-450 BM3. , 1997, Biochemistry.
[5] M. Daffé,et al. The envelope layers of mycobacteria with reference to their pathogenicity. , 1998, Advances in microbial physiology.
[6] Claudia S Maier,et al. A covalent modification of NADP+ revealed by the atomic resolution structure of FprA, a Mycobacterium tuberculosis oxidoreductase. , 2002, Biochemistry.
[7] R. Feyereisen,et al. Interaction of NADP(H) with oxidized and reduced P450 reductase during catalysis. Studies with nucleotide analogues. , 2000, Biochemistry.
[8] J. I. Pedersen,et al. Purification of NADPH-ferredoxin reductase from rat liver mitochondria. , 1978, Biochimica et biophysica acta.
[9] S. Takemori,et al. The purification and properties of NADPH‐adrenodoxin reductase from bovine adrenocortical mitochondria , 1972, FEBS letters.
[10] M. Waterman,et al. Characterization and catalytic properties of the sterol 14alpha-demethylase from Mycobacterium tuberculosis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[11] C. Locht,et al. Activation of the pro-drug ethionamide is regulated in mycobacteria. , 2000, The Journal of biological chemistry.
[12] J. I. Pedersen,et al. Purification of NADPH-ferrodoxin reductase from rat liver mitochondria , 1978 .
[13] G. Schulz,et al. Crystal structures of adrenodoxin reductase in complex with NADP+ and NADPH suggesting a mechanism for the electron transfer of an enzyme family. , 2000, Biochemistry.
[14] N. Scrutton,et al. Expression and thermodynamic characterisation of the Mycobacterium tuberculosis adrenodoxin reductase homologue FprA , 2002 .
[15] B. Barrell,et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence , 1998, Nature.
[16] V. Massey,et al. Determination of dissociation constants and specific rate constants of enzyme-substrate (or protein-ligand) interactions from rapid reaction kinetic data. , 1975, The Journal of biological chemistry.
[17] R. Baxter,et al. Characterisation of flavodoxin NADP+ oxidoreductase and flavodoxin; key components of electron transfer in Escherichia coli. , 1998, European journal of biochemistry.
[18] B. Barrell,et al. Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2) , 2002, Nature.
[19] N. Scrutton,et al. Stopped-flow kinetic studies of flavin reduction in human cytochrome P450 reductase and its component domains. , 2001, Biochemistry.
[20] D W Nebert,et al. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. , 1996, Pharmacogenetics.
[21] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[22] Malcolm D. Walkinshaw,et al. Atomic Structure of Mycobacterium tuberculosis CYP121 to 1.06 Å Reveals Novel Features of Cytochrome P450* , 2003, The Journal of Biological Chemistry.
[23] T. Shimada,et al. Twenty years of biochemistry of human P450s: purification, expression, mechanism, and relevance to drugs. , 1998, Drug metabolism and disposition: the biological fate of chemicals.
[24] D. Tew. Inhibition of cytochrome P450 reductase by the diphenyliodonium cation. Kinetic analysis and covalent modifications. , 1993, Biochemistry.
[25] A. Munro,et al. Determination of the redox properties of human NADPH-cytochrome P450 reductase. , 2001, Biochemistry.
[26] N. Scrutton,et al. Stopped-flow kinetic studies of electron transfer in the reductase domain of neuronal nitric oxide synthase: re-evaluation of the kinetic mechanism reveals new enzyme intermediates and variation with cytochrome P450 reductase. , 2002, The Biochemical journal.
[27] A. Munro,et al. Fluorescence analysis of flavoproteins. , 1999, Methods in molecular biology.
[28] U. Heinemann,et al. Adrenodoxin: Structure, stability, and electron transfer properties , 2000, Proteins.
[29] N. C. Price,et al. Expression, purification and spectroscopic characterization of the cytochrome P450 CYP121 from Mycobacterium tuberculosis. , 2002, Journal of inorganic biochemistry.
[30] T. Ost,et al. Phenylalanine 393 exerts thermodynamic control over the heme of flavocytochrome P450 BM3. , 2001, Biochemistry.
[31] P. Ortiz de Montellano,et al. Active-site topology of bovine cholesterol side-chain cleavage cytochrome P450 (P450scc) and evidence for interaction of tyrosine 94 with the side chain of cholesterol. , 1995, Archives of biochemistry and biophysics.
[32] S K Chapman,et al. Probing the NADPH-binding site of Escherichia coli flavodoxin oxidoreductase. , 2000, The Biochemical journal.
[33] P. Dutton. Redox potentiometry: determination of midpoint potentials of oxidation-reduction components of biological electron-transfer systems. , 1978, Methods in enzymology.
[34] S. Fujii,et al. The semiquinone state of NADPH-adrenodoxin oxidoreductase in the course of anaerobic reduction with NADPH. , 1986, Journal of biochemistry.
[35] H. Hori,et al. Adrenodoxin-cytochrome P450scc interaction as revealed by EPR spectroscopy: comparison with the putidaredoxin-cytochrome P450cam system. , 2001, Journal of biochemistry.
[36] Lung Disease,et al. Anti-tuberculosis drug resistance in the world : the WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance , 1997 .
[37] T. Poulos,et al. Crystal structure of cytochrome P450 14α-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[38] N. Scrutton,et al. Relaxation kinetics of cytochrome P450 reductase: internal electron transfer is limited by conformational change and regulated by coenzyme binding. , 2002, Biochemistry.
[39] G. Zanetti,et al. Mycobacterium tuberculosis FprA, a novel bacterial NADPH-ferredoxin reductase. , 2002, European journal of biochemistry.
[40] A. Munro,et al. Bacterial cytochromes P‐450 , 1996, Molecular microbiology.
[41] Gleb Bourenkov,et al. Adrenodoxin Reductase-Adrenodoxin Complex Structure Suggests Electron Transfer Path in Steroid Biosynthesis* , 2001, The Journal of Biological Chemistry.
[42] S. Daff,et al. Calmodulin Activates Electron Transfer through Neuronal Nitric-oxide Synthase Reductase Domain by Releasing an NADPH-dependent Conformational Lock* , 2002, The Journal of Biological Chemistry.